JP2016526571A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526571A5
JP2016526571A5 JP2016525409A JP2016525409A JP2016526571A5 JP 2016526571 A5 JP2016526571 A5 JP 2016526571A5 JP 2016525409 A JP2016525409 A JP 2016525409A JP 2016525409 A JP2016525409 A JP 2016525409A JP 2016526571 A5 JP2016526571 A5 JP 2016526571A5
Authority
JP
Japan
Prior art keywords
och
acceptable salt
pharmaceutically acceptable
pain
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016525409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016526571A (ja
JP6605462B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/045675 external-priority patent/WO2015006280A1/en
Publication of JP2016526571A publication Critical patent/JP2016526571A/ja
Publication of JP2016526571A5 publication Critical patent/JP2016526571A5/ja
Application granted granted Critical
Publication of JP6605462B2 publication Critical patent/JP6605462B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016525409A 2013-07-10 2014-07-08 イオンチャネルのモジュレーターとしての縮合ピペリジンアミド Expired - Fee Related JP6605462B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361844499P 2013-07-10 2013-07-10
US61/844,499 2013-07-10
PCT/US2014/045675 WO2015006280A1 (en) 2013-07-10 2014-07-08 Fused piperidine amides as modulators of ion channels

Publications (3)

Publication Number Publication Date
JP2016526571A JP2016526571A (ja) 2016-09-05
JP2016526571A5 true JP2016526571A5 (cg-RX-API-DMAC10.html) 2017-08-17
JP6605462B2 JP6605462B2 (ja) 2019-11-13

Family

ID=51230209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016525409A Expired - Fee Related JP6605462B2 (ja) 2013-07-10 2014-07-08 イオンチャネルのモジュレーターとしての縮合ピペリジンアミド

Country Status (13)

Country Link
US (1) US10233191B2 (cg-RX-API-DMAC10.html)
EP (1) EP3019478B1 (cg-RX-API-DMAC10.html)
JP (1) JP6605462B2 (cg-RX-API-DMAC10.html)
KR (1) KR102306951B1 (cg-RX-API-DMAC10.html)
CN (1) CN105473554B (cg-RX-API-DMAC10.html)
AU (1) AU2014287471C1 (cg-RX-API-DMAC10.html)
CA (1) CA2917198C (cg-RX-API-DMAC10.html)
ES (1) ES2780699T3 (cg-RX-API-DMAC10.html)
IL (1) IL243495B (cg-RX-API-DMAC10.html)
MX (1) MX368728B (cg-RX-API-DMAC10.html)
RU (1) RU2741810C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201600082VA (cg-RX-API-DMAC10.html)
WO (1) WO2015006280A1 (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108699015A (zh) 2015-12-18 2018-10-23 默沙东公司 对电压门控性钠通道具有选择性活性的羟基烷基胺-和羟基环烷基胺-取代的二胺-芳基磺胺化合物
KR102079844B1 (ko) 2016-09-20 2020-02-20 가톨릭대학교 산학협력단 담석 용해제를 포함하는 담낭 질환 치료용 약학 조성물
US11071721B2 (en) 2016-12-02 2021-07-27 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
WO2018155260A1 (ja) * 2017-02-23 2018-08-30 株式会社Ihi Ohラジカル検出プローブ、ohラジカル測定装置、および、ohラジカル測定方法
CN119613408A (zh) 2017-07-14 2025-03-14 豪夫迈·罗氏有限公司 二环酮化合物及其使用方法
CN109574927A (zh) * 2017-09-29 2019-04-05 浙江海正药业股份有限公司 N-(取代磺酰基)苯甲酰胺类衍生物及其制备方法和医药用途
MX2020003451A (es) 2017-10-31 2020-08-03 Hoffmann La Roche Sulfonas y sulfoxidos biciclicos y metodos de uso de los mismos.
WO2020054657A1 (ja) * 2018-09-10 2020-03-19 科研製薬株式会社 新規ヘテロ芳香族アミド誘導体及びそれを含有する医薬
CN113302193B (zh) 2019-01-11 2026-05-29 豪夫迈·罗氏有限公司 双环吡咯并三唑酮化合物及其使用方法
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
KR20250133471A (ko) 2020-02-18 2025-09-05 길리애드 사이언시즈, 인코포레이티드 항바이러스 화합물
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
AU2022256476B2 (en) 2021-04-16 2025-06-05 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
UY39881A (es) 2021-08-02 2023-06-15 Eurofarma Laboratorios S A “COMPUESTOS N-ACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS”
UY39882A (es) 2021-08-02 2023-06-15 Eurofarma Laboratorios S A COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS
CA3228162A1 (en) 2021-08-18 2023-02-23 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
WO2024159287A1 (pt) 2023-01-30 2024-08-08 Eurofarma Laboratórios S.A. Hidroxamatos bloqueadores de nav 1.7 e/ou nav 1.8, seus processos de obtenção, composições, usos, métodos de tratamento destes e kits
AR131715A1 (es) 2023-01-30 2025-04-23 Eurofarma Laboratorios S A AMIDAS BLOQUEADORAS DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y KITS
PY2404093A (es) 2023-01-30 2024-10-03 Eurofarma Laboratorios S A Hidrazidas bloqueadoras de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de los mismos y kits
WO2024159285A1 (pt) 2023-01-30 2024-08-08 Eurofarma Laboratórios S.A. Compostos aril piridinas bloqueadores de nav 1.7 e/ou nav 1.8, seus processos de obtenção, composições, usos, métodos de tratamento destes e kits
PY2404641A (es) 2023-01-30 2024-10-03 Eurofarma Laboratorios S A COMPUESTOS FENÓLICOS BLOQUEADORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, SUS COMPOSICIONES, SUS USOS, LOS MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y SUS KITS
CN119285621B (zh) * 2024-12-13 2025-07-18 嘉兴安帝康生物科技有限公司 作为钠通道调节剂的四氢呋喃甲酰胺类化合物及其在医药上的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
SE7509022L (sv) 1974-09-09 1976-03-10 Du Pont Foreningar med analgetisk verkan
DE2655150A1 (de) 1975-12-16 1977-06-23 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4301290A (en) * 1975-12-16 1981-11-17 Sandoz Ltd. Organic compounds
PT68934A (en) * 1977-12-27 1979-01-01 Lilly Co Eli Process for preparing 4a-aryl-octahydro-1h-2-pyrindines
DE2907461A1 (de) * 1978-03-10 1979-09-20 Sandoz Ag Isochinolinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE4427648A1 (de) 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
JP2003327534A (ja) * 1999-11-30 2003-11-19 Toray Ind Inc 頻尿若しくは尿失禁の治療又は予防剤
EP1663994B1 (en) * 2003-08-05 2012-03-07 Vertex Pharmaceuticals Incorporated Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
WO2008130319A2 (en) * 2007-04-23 2008-10-30 Astrazeneca Ab Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
WO2009005459A1 (en) * 2007-06-29 2009-01-08 Astrazeneca Ab Phenyl-1,2, 3,4-tetrahydroisoquinolinone derivatives and their use in the treatment of a pain disorder
WO2010151597A1 (en) * 2009-06-26 2010-12-29 Schering Corporation Methods for using pyrrolo-benzo-1,4-diazines as sodium channel blockers
EP2491034B1 (en) * 2009-10-23 2013-12-18 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as orexin receptor modulators
KR101923367B1 (ko) * 2011-02-02 2018-12-04 버텍스 파마슈티칼스 인코포레이티드 이온 채널의 조절제로서의 피롤로피라진―스피로사이클릭 피페리딘 아미드

Similar Documents

Publication Publication Date Title
JP2014508169A5 (cg-RX-API-DMAC10.html)
ES2665073T3 (es) Inhibidores de serina/treonina cinasa
JP2014508756A5 (cg-RX-API-DMAC10.html)
RU2563030C2 (ru) Сульфонамидные соединения, обладающие антагонистической активностью в отношении trpm8
JP2014504642A5 (cg-RX-API-DMAC10.html)
RU2455994C2 (ru) Пиримидиновые производные
JP6866967B2 (ja) サイクリン依存性キナーゼcdk9の新規阻害剤
SG11202109020QA (en) N-substituted indoles and other heterocycles for treating brain disorders
RU2016151727A (ru) Нейроактивные стероиды, композиции и их применения
CA2739739C (en) Sulfoximine-substituted anilino-pyrimidine derivatives as cdk inhibitors, production and use thereof as medicinal products
ES2824801T3 (es) Sal de compuesto heterocíclico sustituido con halógeno
RU2506261C2 (ru) Производные хиназолина
RU2016104080A (ru) Амиды конденсированного пиперидина в качестве модуляторов ионных каналов
EP4196228A1 (en) N-cyclyl-sulfonamides useful for inhibiting raf
AU2014249233A1 (en) Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
CA3191829A1 (en) Cd73 inhibitor and application thereof in medicine
CN102134218A (zh) 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
JP2020534373A (ja) キナーゼ阻害剤としての環状イミノピリミジン誘導体
JP2025066800A (ja) Bax阻害剤およびその使用
CN114349738A (zh) 一类靶向降解cdk2的小分子缀合物及其应用
CN104119332B (zh) 作为蛋白激酶抑制剂的苯并杂环化合物及其制备方法和用途
JP2021512959A (ja) ピラゾロ[1,5−a][1,3,5]トリアジン−2−アミン誘導体、その製造法、およびその医薬用途
DE102009015070A1 (de) Aminocabonylamino-substituierte Anilino-Pyrimidinderivate als Tyk-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
JP2008543972A5 (cg-RX-API-DMAC10.html)
RU2005135850A (ru) Замещенные изохромановые соединения для лечения метаболических расстройств, рака и другие заболеваний